Nisa Investment Advisors LLC Purchases 1,956 Shares of CVS Health Co. (NYSE:CVS)

Nisa Investment Advisors LLC raised its position in shares of CVS Health Co. (NYSE:CVS) by 0.5% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 368,105 shares of the pharmacy operator’s stock after purchasing an additional 1,956 shares during the quarter. Nisa Investment Advisors LLC’s holdings in CVS Health were worth $29,066,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Bryn Mawr Capital Management LLC lifted its position in shares of CVS Health by 74.0% during the 3rd quarter. Bryn Mawr Capital Management LLC now owns 43,213 shares of the pharmacy operator’s stock valued at $3,017,000 after buying an additional 18,385 shares in the last quarter. Value Partners Investments Inc. lifted its position in shares of CVS Health by 26.5% during the 3rd quarter. Value Partners Investments Inc. now owns 991,601 shares of the pharmacy operator’s stock valued at $69,261,000 after buying an additional 207,702 shares in the last quarter. Sonora Investment Management Group LLC lifted its position in shares of CVS Health by 1.6% during the 3rd quarter. Sonora Investment Management Group LLC now owns 50,488 shares of the pharmacy operator’s stock valued at $3,525,000 after buying an additional 774 shares in the last quarter. Checchi Capital Advisers LLC lifted its position in shares of CVS Health by 2.3% during the 3rd quarter. Checchi Capital Advisers LLC now owns 10,405 shares of the pharmacy operator’s stock valued at $726,000 after buying an additional 233 shares in the last quarter. Finally, Personal CFO Solutions LLC lifted its position in shares of CVS Health by 2.6% during the 3rd quarter. Personal CFO Solutions LLC now owns 19,355 shares of the pharmacy operator’s stock valued at $1,351,000 after buying an additional 491 shares in the last quarter. 80.66% of the stock is owned by hedge funds and other institutional investors.

CVS Health Stock Performance

NYSE CVS opened at $74.58 on Monday. The business’s 50 day moving average price is $76.08 and its 200-day moving average price is $73.78. The company has a market cap of $93.86 billion, a P/E ratio of 11.54, a P/E/G ratio of 0.99 and a beta of 0.52. The company has a debt-to-equity ratio of 0.77, a quick ratio of 0.63 and a current ratio of 0.86. CVS Health Co. has a fifty-two week low of $64.41 and a fifty-two week high of $83.25.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, February 7th. The pharmacy operator reported $2.12 earnings per share for the quarter, topping the consensus estimate of $2.01 by $0.11. CVS Health had a return on equity of 15.25% and a net margin of 2.33%. The business had revenue of $93.81 billion during the quarter, compared to analysts’ expectations of $90.58 billion. During the same period in the prior year, the business earned $1.99 EPS. The business’s revenue for the quarter was up 11.9% compared to the same quarter last year. Sell-side analysts predict that CVS Health Co. will post 8.33 earnings per share for the current year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, May 1st. Shareholders of record on Monday, April 22nd will be issued a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 3.57%. The ex-dividend date is Friday, April 19th. CVS Health’s dividend payout ratio is 41.18%.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on the company. SVB Leerink assumed coverage on CVS Health in a report on Monday, February 26th. They issued an “outperform” rating and a $88.00 price target on the stock. Leerink Partnrs reissued an “outperform” rating on shares of CVS Health in a report on Monday, February 26th. Cantor Fitzgerald reissued an “overweight” rating and issued a $87.00 price target on shares of CVS Health in a report on Thursday. HSBC assumed coverage on CVS Health in a report on Friday, December 22nd. They issued a “buy” rating and a $94.00 price target on the stock. Finally, StockNews.com cut CVS Health from a “buy” rating to a “hold” rating in a report on Thursday, February 15th. Four equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. According to MarketBeat, CVS Health presently has an average rating of “Moderate Buy” and a consensus target price of $89.44.

Insiders Place Their Bets

In other CVS Health news, EVP Prem S. Shah sold 29,473 shares of the company’s stock in a transaction on Friday, February 16th. The stock was sold at an average price of $76.95, for a total value of $2,267,947.35. Following the completion of the sale, the executive vice president now directly owns 39,765 shares in the company, valued at approximately $3,059,916.75. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 0.25% of the company’s stock.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.